Arctic Bioscience Share Price

Equities

ABS

NO0010859580

Pharmaceuticals

Market Closed - Oslo Bors 15:45:00 26/04/2024 BST 5-day change 1st Jan Change
9.85 NOK 0.00% Intraday chart for Arctic Bioscience -3.43% -6.19%

Financials

Sales 2024 * 57M 5.17M 414M Sales 2025 * 79M 7.17M 573M Capitalization 250M 22.67M 1.81B
Net income 2024 * -30M -2.72M -218M Net income 2025 * -50M -4.54M -363M EV / Sales 2024 * 1.63 x
Net cash position 2024 * 157M 14.24M 1.14B Net cash position 2025 * 106M 9.61M 769M EV / Sales 2025 * 1.82 x
P/E ratio 2024 *
-8.19 x
P/E ratio 2025 *
-4.94 x
Employees 17
Yield 2024 *
-
Yield 2025 *
-
Free-Float 38.42%
More Fundamentals * Assessed data
Dynamic Chart
1 week-3.43%
Current month-1.30%
1 month+3.68%
3 months-6.19%
6 months+25.96%
Current year-6.19%
More quotes
1 week
9.85
Extreme 9.85
10.40
1 month
9.40
Extreme 9.4
10.50
Current year
8.80
Extreme 8.8
12.00
1 year
7.54
Extreme 7.54
12.00
3 years
7.54
Extreme 7.54
25.00
5 years
7.54
Extreme 7.54
32.00
10 years
7.54
Extreme 7.54
32.00
More quotes
Managers TitleAgeSince
Founder 58 31/12/10
Chief Executive Officer 52 28/02/22
Director of Finance/CFO 45 31/03/22
Members of the board TitleAgeSince
Director/Board Member 44 31/12/20
Director/Board Member 55 31/12/19
Founder 66 31/12/10
More insiders
Date Price Change Volume
26/04/24 9.85 0.00% 0
25/04/24 9.85 0.00% 0
24/04/24 9.85 0.00% 0
23/04/24 9.85 -5.29% 900
22/04/24 10.4 +1.96% 4,265

Real-time Oslo Bors, April 26, 2024 at 03:45 pm

More quotes
Arctic Bioscience AS is a Norway-based biotech company developing and commercializing both pharmaceutical and nutraceutical products based on the properties of herring roe oil. Arctic Bioscience’s purpose is to provide people with autoimmune disorders an effective and healthy therapy based on marine membrane lipids. The Company is developing HRO350 - a novel investigational drug candidate. HRO350 is being developed for treatment of patients with mild-to-moderate psoriasis. The Company's product portfolio includes, among others, Romega, which is a producer of an omega-3 dietary supplement made from herring roe in a form of a capsule, as well as herring caviar oil and herring caviar protein offered to Business-to-Business (B2B) customers. Arctic Bioscience AS has three subsidiaries Arctic Nutrition AS, Romega AS and Arctic Biopharma AS.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
9.85 NOK
Average target price
10 NOK
Spread / Average Target
+1.52%
Consensus

Annual profits - Rate of surprise